Fundamentals of Molecular Virology -  - E-Book

Fundamentals of Molecular Virology E-Book

0,0
140,99 €

-100%
Sammeln Sie Punkte in unserem Gutscheinprogramm und kaufen Sie E-Books und Hörbücher mit bis zu 100% Rabatt.
Mehr erfahren.
Beschreibung

Comprehensive coverage of major families of viruses, including human pathogens and viruses of organisms from bacteria to plants, with updated information on antiviral drugs, vaccines, antiviral immunity, and gene therapy

Fundamentals of Molecular Virology is a textbook designed for university students learning about viruses at the undergraduate or graduate levels. Chapters contributed by prominent virologists cover many of the major virus families. Each chapter is designed to tell a story about the viruses covered, including information on discovery, diseases and pathogenesis, virus structure, steps in replication, and interaction with cellular signaling pathways. This approach portrays the “personality” of each virus, helping students to learn the material and build up their knowledge of virology starting with smaller and simpler viruses and proceeding to more complex viruses.

Major importance is given to viruses that infect humans and cause disease, but coverage is broad, including viruses of bacteria, Archaea, algae, invertebrates, and plants. Information boxes highlight applications and research directions of particular significance. Chapters conclude with sections presenting fundamental concepts, review questions, and lists of key terms, which are defined in a glossary at the end of the book.

This 3rd edition of Fundamentals of Molecular Virology includes detailed information on the recent COVID-19 pandemic and mRNA vaccine technology, additional sections on pathogenic herpesviruses, and updates on recent outbreaks of Zika virus, Ebola virus and mpox diseases. New chapters describe hepatitis C virus, rhabdoviruses, viruses of invertebrates, oncolytic viruses, and virus-mediated gene therapy. All chapters, including those on innate and adaptive immune responses to virus infections, virus vaccines, and antiviral agents, were revised and updated.

Sie lesen das E-Book in den Legimi-Apps auf:

Android
iOS
von Legimi
zertifizierten E-Readern

Seitenzahl: 1851

Veröffentlichungsjahr: 2025

Bewertungen
0,0
0
0
0
0
0
Mehr Informationen
Mehr Informationen
Legimi prüft nicht, ob Rezensionen von Nutzern stammen, die den betreffenden Titel tatsächlich gekauft oder gelesen/gehört haben. Wir entfernen aber gefälschte Rezensionen.



Third Edition

Fundamentals of MolecularVIROLOGY

Edited by

CHRISTOPHER D. RICHARDSON

AND

NICHOLAS H. ACHESON

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial intelligence technologies or similar technologies.

Published by John Wiley & Sons, Inc., Hoboken, New Jersey.Published simultaneously in Canada.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per‐copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750‐8400, fax (978) 750‐4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748‐6011, fax (201) 748‐6008, or online at http://www.wiley.com/go/permission.

The manufacturer’s authorized representative according to the EU General Product Safety Regulation is Wiley‐VCH GmbH, Boschstr. 12, 69469 Weinheim, Germany, e‐mail: [email protected].

Trademarks: Wiley and the Wiley logo are trademarks or registered trademarks of John Wiley & Sons, Inc. and/or its affiliates in the United States and other countries and may not be used without written permission. All other trademarks are the property of their respective owners. John Wiley & Sons, Inc. is not associated with any product or vendor mentioned in this book.

Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.

For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762‐2974, outside the United States at (317) 572‐3993 or fax (317) 572‐4002.

Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www.wiley.com.

Library of Congress Cataloging‐in‐Publication Data Applied for:

Paperback ISBN 9781119885863

Cover Design: WileyCover Images: © Adenosine/Wikimedia Commons, © Thomas Splettstoesser/Wikimedia Commons, © Moonnoon/Shutterstock, © Kateryna Kon/Shutterstock

Nicholas H. Acheson dedicates this book to four mentors whose enthusiasm for virology stimulated his interest when he was a student, and who encouraged him to follow his own path.

Johns Hopkins IIIJames D. WatsonIgor TammPurnell Choppin

Christopher D. Richardson dedicates this textbook to his mentors and friends who helped guide his career in a journey through the world of viruses, starting in Vancouver and progressing to New York, Bethesda, Montreal, Toronto, and culminating in Halifax. Their continuous support and encouragement were genuinely appreciated.

Dennis E. VancePurnell W. ChoppinIgor TammRobert A. LambRobert A. LazzariniDavid Lorne TyrrellPierre TalbotDavid Y. ThomasTak Wah MakFei‐Fei Liu

PREFACE

This book is written for students who are learning about viruses for the first time in a university course at the undergraduate or graduate level. As the title implies, it concentrates on the molecular mechanisms of virus replication and on the interactions between viruses and the cells in which they replicate. The book approaches learning about virology by presenting chapters, many of which cover a specific virus family, using one or two well‐studied viruses as examples. Several other chapters discuss a variety of the many viruses that infect Archaea, algae, or invertebrates. These chapters are each designed to tell a story about the viruses being considered and to portray their “personality”, with the idea that this will help students learn about and remember each virus group.

This organizational scheme has been used in a number of successful virology textbooks, including Salvador Luria’s classic 1953 book, General Virology. Luria was one of the founding members of the “phage group,” a coalition of physicists, biologists, and chemists who, during the 1940s, chose to study bacteriophages in order to understand the molecular basis of life and, in doing so, invented the field of molecular biology. Their approach was to study how the proteins and nucleic acids of viruses interact with cellular molecules and organelles, transforming the cell into a factory that can produce many new progeny virus particles. Their underlying hope, which was largely achieved, was to use viruses as a tool to help understand how cells work.

The amount of knowledge that has accumulated about viruses has expanded enormously in recent years, as in many other areas of biomedical sciences. Fields Virology has become the classic reference book for knowledge about human and animal viruses during the past 40 years; that book is also organized in chapters that cover specific virus families. Our own teaching experience and conversations with numerous colleagues have convinced us that there is a real need for a concise, up‐to‐date textbook organized around the concept of virus families and designed specifically for teaching university students.

The problem was to make such a book accessible to beginning students without oversimplifying the material. Our approach was to ask a number of prominent virology researchers and teachers to write chapters on viruses that they knew well, using a set of criteria that we provided. We then edited and sometimes rewrote these chapters into a common style, and, in many cases, we created or redesigned the illustrations.

No individual could possibly write knowledgeably about the large spectrum of viruses that a virology course should cover, so a collaborative approach was necessary. However, a textbook that is an effective learning tool must have a coherent organization and a clear, consistent style of writing and illustration. Our job has been to craft the original chapters that we received into what we hope are readable and easily understood units.

This textbook emphasizes virus replication strategies; it is directed toward university students studying microbiology, cell and molecular biology, and the biomedical sciences. It does not go deeply into pathogenesis, epidemiology, or disease symptoms. However, substantial information and stories about medical and historical aspects of virology are included, particularly in the introductory sections of each chapter. Students who understand the diseases caused by particular viruses, and their importance in human history, may be motivated to learn more about those viruses.

What is New in the Third Edition

The second edition of this book, published in 2011, expanded coverage to include additional viruses and chapters on innate and adaptive immune responses to virus infection. New full‐color figures were introduced. It was well‐received and was adopted as a text for many university‐based virology courses in North America and overseas. Work on the current third edition began shortly before the COVID‐19 pandemic, when Christopher Richardson accepted the job of planning and coordinating this revision. Chris began to recruit virology researchers and educators to update and revise existing chapters, as well as soliciting several additional chapters. The COVID‐19 pandemic inevitably slowed down work on this revision but also gave us the chance to include detailed descriptions of the pandemic and its life‐changing effects on the entire planet, in the chapter on coronaviruses.

All chapters in this book were reviewed and updated, some in depth. However, the organization and content of each chapter were retained in most cases. We have therefore cited on the title page of each chapter the names of the original contributors as well as those of the individuals who revised or rewrote the chapter.

This third edition includes five new chapters: (1) “Bacteriophage T4,” one of the best‐studied and most complex phages; (2) “Hepatitis C Virus,” the story about a relatively recent viral disease for which efficient antiviral agents that cure infected individuals have been developed; (3) “Viruses of Invertebrates,” a growing field with many diverse viruses, which has developed through the efforts of high‐throughput sequencing, resulting in the discovery of thousands of viral genomes derived from environmental samples; (4) “Oncolytic Viral Agents,” a field that is starting to show some promise for treatment of certain human cancers; and (5) “Virus‐Mediated Gene Therapy,” a field under development for decades that has now progressed from its infancy to adolescence. This last chapter discusses how viral vectors have been harnessed to yield clinical successes in treating inherited human diseases and some cancers. The field has embraced CRISPR/Cas gene editing, which evolved from studying defense mechanisms in phage infections of bacteria. The merging of these technologies shows promise in treating debilitating diseases such as sickle cell disease, thalassemia, Parkinson’s disease, congenital blindness, amyloidosis, and cancer, to name a few.

How to Use this Book

This textbook is designed to be used in a modular fashion. No course would be expected to use all chapters in the book, nor necessarily in the same order in which they appear. The organization of the book gives wide latitude to course coordinators to make their own choices of which virus groups will be covered. Chapters are designed to accompany a 50‐minute lecture on the subject, or, in some cases, two or three such lectures. It should be possible to read each chapter in 30–60 minutes, including examination of figures and tables. Lecturers might want to supplement material given in the text with experimental methods or results, which are not covered because of lack of space.

The book is organized into 11 sections and 42 chapters. Four introductory chapters in Section I cover the history of virology and the virus life cycle, virus structure, virus classification, and the entry of viruses into animal cells. Five chapters in Section II cover well‐studied bacteriophages. These are included because bacteriophages are among the best‐known viruses, and because much of our knowledge of molecular biology and virology began with their study. Furthermore, bacteriophages are the source of many tools commonly used in modern molecular and cell biology laboratories. A final chapter in Section II covers exciting new knowledge about the sometimes‐bizarre viruses that infect archaea, members of the third domain of life, alongside bacteria and eukaryotes.

Sections III through VII cover viruses of eukaryotes, with an emphasis on viruses that infect humans and other vertebrates. The division into sections is based on the nature of the viral genome and viral replication strategies: positive‐strand RNA viruses (Section III), negative‐strand and double‐stranded RNA viruses (Section IV), DNA viruses (Sections V and VI), and viruses that use reverse transcriptase (Section VII). Within a section, smaller and simpler viruses are discussed first, followed by larger and more complex viruses. In this way, concepts that are learned about simpler viruses can be applied when more complex viruses are encountered.

Section VIII covers small infectious entities that are not viruses: viroids, which are virus‐like nucleic acids that replicate but code for no proteins; and prions, which are infectious proteins that contain no detectable nucleic acid. Section IX includes chapters on viruses that infect algae, invertebrates, and plants. The “giant” viruses are discussed in the chapter on viruses of algae. Section X covers host defenses against virus infection, and Section XI has been expanded to include not only chapters on vaccines and antiviral chemotherapy but also two new chapters on oncolytic viruses and viral gene therapy.